drugset / Trial / NCT01515202
Japanese Phase 1 Multiple Ascending Dose Study
RandomizedParallel-groupQuadruple-blindTreatment
Summary
The purpose of this clinical study is to assess the safety and tolerability of multiple oral doses of BMS-823778 in healthy Japanese subjects and Japanese patients with Type 2 Diabetes Mellitus.
Timeline
- Start
- 2012-03
- Primary completion
- 2012-09
- Completion
- 2012-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BMS-823778 | Small molecule | 2 mg | Oral |
| Subject | BMS-823778 | Small molecule | 12 mg | Oral |
| Subject | BMS-823778 | Small molecule | 15 mg | Oral |
| Subject | BMS-823778 | Small molecule | 25 mg | Oral |